Portfolio

HLEND seeks to build a diversified portfolio of senior secured private credit investments in resilient, market-leading, upper-middle market companies that operate primarily in non-cyclical sectors.

Data as of December 31, 2025

$25.3B

Investments at Fair Value

9.4%

Portfolio Yield at Fair Value1

93%

Private Investments2

96%

First Lien Exposure3

99%

Floating Rate4

$255M

Weighted Average EBITDA5

Portfolio Companies89

Clear Filters
Company Name
Industry
Investment Type
Reference Rate & Spread11
Par Amount (thousands)
Amortized Cost (thousands)
Fair Value (thousands)
% of Total Portfolio
BLY US Holdings Inc. (Boart Longyear Management) Metals & Mining 1st Lien Senior Secured Debt S + 6.00% $57,265 56,316 56,000 0.22%
BLY US Holdings Inc. (Boart Longyear Management) Metals & Mining 1st Lien Senior Secured Debt P + 5.00% $15,342 14,962 15,003 0.06%
BMC Software Inc. (BMC Software) Software 1st Lien Senior Secured Debt S + 3.00% $2,978 2,947 2,973 0.01%
BP Purchaser, LLC (BOX Partners) Containers & Packaging 1st Lien Senior Secured Debt S + 5.50% $28,402 28,165 22,625 0.09%
Baart Programs, Inc. Health Care Providers & Services 1st Lien Senior Secured Debt SF + 5.00% $9,968 9,935 7,544 0.03%
Bain Capital Credit CLO 2024-3 Ltd (Bain Capital Credit CLO, Limit) Structured Finance Structured Finance investments S + 6.25% $2,000 2,000 2,022 0.01%
Bakelite US Holdco Inc (Bakelite) Chemicals 1st Lien Senior Secured Debt S + 3.75% $6,145 6,092 5,973 0.02%
Baker Tilly Advisory Group, LP (Baker Tilly) Professional Services 1st Lien Senior Secured Debt S + 4.50% $27,686 -297 -51 0.00%
Baker Tilly Advisory Group, LP (Baker Tilly) Professional Services 1st Lien Senior Secured Debt S + 4.75% $117,224 115,846 117,224 0.46%
Baker Tilly Advisory Group, LP (Baker Tilly) Professional Services 1st Lien Senior Secured Debt S + 4.25% $28,427 28,169 28,406 0.11%
Bamboo US BidCo LLC (Simtra BioPharma Solutions) Life Sciences Tools & Services 1st Lien Senior Secured Debt S + 5.00% $103,629 101,142 103,150 0.41%
Bamboo US BidCo LLC (Simtra BioPharma Solutions) Life Sciences Tools & Services 1st Lien Senior Secured Debt E + 5.00% €62,490 64,810 73,419 0.29%
Bamboo US BidCo LLC (Simtra BioPharma Solutions) Life Sciences Tools & Services 1st Lien Senior Secured Debt S + 5.25% $21,254 -398 - 0.00%
Barings CLO Ltd 2024-IV (Babson CLO Ltd) Structured Finance Structured Finance investments S + 5.95% $4,500 4,500 4,552 0.02%
Bausch + Lomb Corporation (Bausch + Lomb) Health Care Equipment & Supplies 1st Lien Senior Secured Debt S + 4.00% $9,963 9,963 9,988 0.04%
Bausch + Lomb Corporation (Bausch + Lomb) Health Care Equipment & Supplies 1st Lien Senior Secured Debt S + 4.25% $39,761 39,580 40,228 0.16%
Bayou Intermediate II, LLC (Cordis) Health Care Equipment & Supplies 1st Lien Senior Secured Debt S + 4.75% $174,044 146,378 146,625 0.58%
Bayou Intermediate II, LLC (Cordis) Health Care Equipment & Supplies 1st Lien Senior Secured Debt S + 5.25% (incl 2.88% PIK) $40,378 15,622 15,685 0.06%
Belron Finance 2019 LLC (Belron) Automobile Components 1st Lien Senior Secured Debt S + 2.25% $14,500 14,463 14,599 0.06%
Benefit Street Partners CLO XXXVI Ltd (Benefit Street Partners CLO Lt) Structured Finance Structured Finance investments S + 5.50% $4,750 4,750 4,795 0.02%
Birdie Bidco, Inc. (Concert Golf Partners) Hotels, Restaurants & Leisure 1st Lien Senior Secured Debt S + 4.50% $153,480 105,692 105,680 0.42%
Blazing Star Shields Direct Parent, LLC (Shields Health Solutions) Health Care Providers & Services 1st Lien Senior Secured Debt S + 6.00% $516,365 484,779 485,551 1.92%
Boreal Bidco (Esker SA) Software 1st Lien Senior Secured Debt E + 7.25% (incl 5.75% PIK) €51,153 54,169 59,160 0.23%
Bottomline Technologies, Inc. Software 1st Lien Senior Secured Debt S + 4.50% $4,851 4,442 4,491 0.02%
Braya Renewable Fuels (Newfoundland) LP Chemicals 1st Lien Senior Secured Debt S + 10.00% $24,017 23,869 22,930 0.09%

Engage with HLEND

Start Here

Footnotes

  1. Computed as (a) the annual stated interest rate or yield plus the annual accretion of discounts and less any annual amortization of premiums, as applicable, on accruing (i) debt and (ii) other income producing securities, divided by (b) total accruing (i) debt and (ii) other income producing securities (at fair value). Actual yields earned over the life of each investment could differ materially from the yields presented above. Please refer to HLEND’s prospectus and filings, including Form 10-Q or Form 10-K for fair value disclosures.
  2. Private Investments represents level 3 investments in the investment portfolio where inputs to the valuation methodology are unobservable and significant to overall fair value measurement. Private investments includes investments in joint ventures.
  3. Based on the aggregate fair value of the investment portfolio as of December 31, 2025.
  4. Percentage based on aggregate fair value of accruing debt.
  5. Calculated with respect to all level 3 investments (or, with respect to weighted average loan to value, all level 3 debt investments) in the investment portfolio for which fair value is determined by the Investment Adviser (in its capacity as the investment adviser of HLEND, with assistance, at least quarterly, from a third-party valuation firm, and overseen by HLEND’s Board of Trustees), and excludes quoted assets and investments in joint ventures. In the case of weighted average EBITDA only, excludes investments with no reported EBITDA or where EBITDA, in the Investment Adviser’s judgement made in its discretion, was not a material component of the original investment thesis, such as loan-to-value-based loans, NAV-based loans or reorganized equity. Weighted average EBITDA is weighted based on the fair value of the total applicable level 3 investments. Loan to value is calculated as net debt through each respective investment tranche in which HLEND holds an investment divided by enterprise value or value of underlying collateral of the portfolio company. Weighted average loan to value is weighted based on the fair value of the total applicable level 3 debt investments. Excludes investments on non-accrual status as of October 31, 2024. Figures are derived from the most recent financial statements from portfolio companies.
  6. Includes “last out” portions of first lien senior secured loans.
  7. Secured debt at the holding company level.
  8. Based on MSCI / S&P Global Industry Classification Standard (“GICS”) industry definition. Totals may not sum due to rounding. 
  9. All figures are as of December 31, 2025 unless otherwise indicated. % of total portfolio shown above is measured as total fair value of investments.
  10. Other includes structured finance investments.
  11. Contractual rates on preferred equity investments may represent preference accruals that are not recognized through investment income of the fund and as such are not included in the calculation of yield. The fair value of these investments may be influenced by the stated preference accrual or a minimum return threshold.